Tags : Sequel SMRT Technology


Illumina Acquires Pacific Biosciences for ~$1.2B with its Sequel SMRT

Shots: Pacific to get $8.00/share making $1.2B as total deal value in cash, with its expected closure in Q2’19 The acquisition is a focus to combine Pacific’s Sequel SMRT Technology for expansion of its biological discovery platform by bringing short- and long-read sequencing technologies together Sequel SMRT (Single-Molecule Real-Time) Technology is an automated system with […]Read More